Triple-negative breast cancer (TNBC) refers to breast cancers not expressing the oestrogen receptor (ER), the progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ERBB2 and breast carcinoma.